AffiliationDepartment of Endocrinology, Christie Hospital NHS Trust, Withington, Manchester, UK M20 4BX.
MetadataShow full item record
AbstractTreatment with cytotoxic chemotherapy and radiotherapy is associated with significant gonadal damage in men, and alkylating agents are the most common agents implicated. The vast majority of men receiving procarbazine-containing regimens for the treatment of lymphomas are rendered permanently infertile, whereas treatment with doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine, and dacarbazine appears to have a significant advantage, with a return to normal fertility in the vast majority of patients. Cisplatin-based chemotherapy for testicular cancer results in temporary azoospermia in most men, with a recovery of spermatogenesis in about 50% of the patients after 2 years and 80% after 5 years. The germinal epithelium is very sensitive to radiation-induced damage, with changes to spermatogonia following as little as 0.2 Gy. Testicular doses of less than 0.2 Gy had no significant effect on FSH levels or sperm counts, whereas doses between 0.2 and 0.7 Gy caused a transient dose-dependent increase in FSH and reduction in sperm concentration, with a return to normal values within 12-24 months. No radiation dose threshold has been defined above which permanent azoospermia is inevitable; however, doses of 1.2 Gy and above are likely to be associated with a reduced risk of recovery of spermatogenesis; the time to recovery, if it is to occur, is also likely to be dose dependent.
CitationSpermatogenesis after cancer treatment: damage and recovery. 2005 (34):12-7 J. Natl. Cancer Inst. Monographs
JournalJournal of the National Cancer Institute. Monographs
- Effect of cancer therapy on pituitary-testicular axis.
- Authors: Howell SJ, Shalet SM
- Issue date: 2002 Oct
- Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
- Authors: van der Kaaij MA, Heutte N, Le Stang N, Raemaekers JM, Simons AH, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Kluin-Nelemans HC, Henry-Amar M, European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group., Groupe d'Etude des Lymphomes de l'Adulte.
- Issue date: 2007 Jul 1
- Testicular function following chemo-radiotherapy.
- Authors: Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G
- Issue date: 2004 Apr 5
- Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
- Authors: van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Weber RF, Pieters R, de Muinck Keizer-Schrama SM
- Issue date: 2007 Dec
- Recovery of spermatogenesis following bone marrow transplantation.
- Authors: Jacob A, Barker H, Goodman A, Holmes J
- Issue date: 1998 Aug